ArticleDose-response : a publication of International Hormesis Society
Red Blood Cell Distribution Width-To-Albumin Ratio and 90-Day Mortality in Sepsis Patients with and Without Sepsis-Induced Coagulopathy: A Retrospective Observational Study Using the MIMIC-IV Database.
Article in Dose-response : a publication of International Hormesis Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The red blood cell distribution width-to-albumin ratio (RAR) has emerged as a novel prognostic biomarker in critically ill patients. However, its association with mortality in sepsis patients, particularly in the context of sepsis-induced coagulopathy (SIC), remains unclear. Methods: This retrospective cohort study analyzed adult sepsis patients from the Medical Information Mart for Intensive Care IV (MIMIC-IV) version 3.1 database. RAR was calculated from the first laboratory measurements within 24 hours of intensive care unit (ICU) admission. The primary outcome was 90-day all-cause mortality. Cox proportional hazards regression, subgroup analyses, and restricted cubic spline (RCS) regression were performed. Discriminative ability was assessed using receiver operating characteristic (ROC) curves. Results: Of 26,854 patients meeting sepsis criteria, 17,499 were excluded due to missing RDW or albumin data. A total of 9,206 sepsis patients were included, with 5,649 (61.4%) meeting SIC criteria. The overall 90-day mortality was 38.1% (absolute rates: 23.9% in the lowest RAR quartile to 55.5% in the highest). In the fully adjusted model (age, sex, SOFA, Charlson Comorbidity Index, infection source, vasopressor use, mechanical ventilation, renal replacement therapy, and lactate), each unit increase in RAR was associated with a 9% increase in mortality risk (hazard ratio [HR]=1.09, 95% confidence interval [CI]: 1.08-1.10, P<0.001). Compared with the lowest quartile, patients in the highest RAR quartile had a significantly higher mortality risk (HR=2.07, 95% CI: 1.91-2.25). The association remained consistent across subgroups. RCS analysis revealed a significant non-linear exposure-response relationship (P for non-linearity <0.001). DeLong testing confirmed that RAR (AUC=0.648) had statistically significantly higher discriminative ability than SOFA score (AUC=0.613, P<0.001) and SIC score (AUC=0.593, P<0.001) for 90-day mortality, though all AUC values indicated moderate discrimination. Conclusions: Elevated RAR was independently associated with increased 90-day mortality after comprehensive covariate adjustment (highest vs. lowest quartile: HR=2.07, 95% CI: 1.91-2.25), with modest but statistically significant incremental discriminative ability over SOFA and SIC scores. As a biomarker derived from routine blood tests, RAR may complement existing tools for early risk stratification in sepsis. These findings are hypothesis-generating and warrant prospective validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.